drugset / Trial / NCT04664595

Requirements of Propofol With Target Controlled Infusions for Supraglottic Airway Devices

NCT04664595 ↗

Completed 40 enrolled Prince of Songkla University
RandomizedParallel-groupDouble-blindTreatment

Summary

to evaluate and compare the effect-site concentration of propofol with the TCI system for second-generation SGA device insertion between the I-gel™, Supreme™, ProSeal™ and Laryngeal Tube Suction II™. to determine the hemodynamic changes during insertion of supraglottic devices in patients undergoing elective surgery and any complications after device insertion.

Timeline

Start
2012-06
Primary completion
2013-06
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule — —

Indications

No indication recorded.